Forward Pharma A/S ADR | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,955.00
88,745.50
93,903.00
139,445.20
109,554.10
82,543.40
Total Accounts Receivable
432.00
1,065.90
847.00
429.20
935.00
448
Other Current Assets
207.00
688.00
5,047.80
659.40
502.00
340
Total Current Assets
3,593.90
90,499.30
99,797.80
140,533.80
110,991.10
83,331.40
Net Property, Plant & Equipment
5.00
9.70
352.00
269.40
12.00
-
Total Investments and Advances
-
127,809.60
82,748.40
5.00
5.00
-
Other Assets
-
4.80
-
-
-
2
Total Assets
3,598.90
218,323.40
182,898.20
163,992.30
111,008.10
83,333.40
ST Debt & Current Portion LT Debt
2,613.00
-
-
-
-
Accounts Payable
1,095.00
1,606.60
3,985.90
2,083.80
1,203.00
Income Tax Payable
-
-
-
202.00
7,039.00
Other Current Liabilities
26,305.60
1,218.00
2,224.90
5,093.40
13,043.00
Total Current Liabilities
30,013.50
2,824.60
6,210.80
7,379.20
21,285.00
Deferred Taxes
-
-
-
23,184.10
43.00
Total Liabilities
30,013.50
2,824.60
6,210.80
7,379.20
21,328.00
Common Equity (Total)
26,414.60
215,498.80
176,687.40
156,613.10
89,680.00
Total Shareholders' Equity
26,414.60
215,498.80
176,687.40
156,613.10
89,680.00
Total Equity
26,414.60
215,498.80
176,687.40
156,613.10
89,680.00
Liabilities & Shareholders' Equity
3,598.90
218,323.40
182,898.20
163,992.30
111,008.10

About Forward Pharma A/S

View Profile
Address
Østergade 24A
Copenhagen CR 1100
Denmark
Employees -
Website http://www.forward-pharma.com
Updated 07/08/2019
Forward Pharma is a biopharmaceutical company, which engages in the research and production of medicinal treatment for multiple sclerosis and psoriasis. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark.